305 related articles for article (PubMed ID: 37143264)
21. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
22. A Comprehensive Review on the Role of Polymers in Ocular Drug Delivery.
Paramjot ; Wadhwa S; Sharma A; Singh SK; Vishwas S; Kumar R; Singh S; Dua K; Chellappan DK; Gupta G
Curr Drug Deliv; 2024; 21(1):16-37. PubMed ID: 36627785
[TBL] [Abstract][Full Text] [Related]
23. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
George A; Shah PA; Shrivastav PS
Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
[TBL] [Abstract][Full Text] [Related]
24. Nanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases.
Fathi-Karkan S; Amiri Ramsheh N; Arkaban H; Narooie-Noori F; Sargazi S; Mirinejad S; Roostaee M; Sargazi S; Barani M; Malahat Shadman S; Althomali RH; Rahman MM
Int J Pharm; 2024 Jun; 658():124226. PubMed ID: 38744414
[TBL] [Abstract][Full Text] [Related]
25. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid in ocular drug delivery.
Zhang X; Wei D; Xu Y; Zhu Q
Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
[TBL] [Abstract][Full Text] [Related]
27. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
Sah AK; Suresh PK
Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
[TBL] [Abstract][Full Text] [Related]
29. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
[No Abstract] [Full Text] [Related]
30. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
31. Nanocarriers for ocular drug delivery: Recent advances and future opportunities.
Amrutkar CS; Patil SB
Indian J Ophthalmol; 2023 Jun; 71(6):2355-2366. PubMed ID: 37322644
[TBL] [Abstract][Full Text] [Related]
32. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
34. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
[TBL] [Abstract][Full Text] [Related]
35. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
Tagami T; Ozeki T
J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
[TBL] [Abstract][Full Text] [Related]
36. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
37. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
[TBL] [Abstract][Full Text] [Related]
38. Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities.
Zhang T; Jin X; Zhang N; Jiao X; Ma Y; Liu R; Liu B; Li Z
Nanotechnology; 2022 Jan; 33(16):. PubMed ID: 34965522
[TBL] [Abstract][Full Text] [Related]
39. An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers.
Shafiq M; Rafique M; Cui Y; Pan L; Do CW; Ho EA
J Control Release; 2023 Oct; 362():446-467. PubMed ID: 37640109
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
